At SCOPE 2025, ConcertAI Announces Major Advances in Trial Technologies for Research Sites and Sponsors [Yahoo! Finance]
NeoGenomics, Inc. (NEO)
Last neogenomics, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.neogenomics.com
Company Research
Source: Yahoo! Finance
Mon, February 3, 2025 at 3:00 PM GMT+1 2 min read AI-enabled research workflows ensure both patient awareness of potentially beneficial clinical trials and the highest productivity and performance CAMBRIDGE, Mass., February 03, 2025 BUSINESS WIRE )--At the opening of SCOPE 2025, ConcertAI and Exigent Research announced the availability of ConcertAI technologies for study feasibility, patient-to-trial matching, and AI-powered study automations across all Exigent research sites and as an integral part of all sponsored studies. The partnership ensures that advanced CARAai™ Generative and Agentic AI solutions are available to provide the highest possible performance and lowest burden for the network's leading community research sites. A few weeks earlier, NeoGenomics and ConcertAI announced the collaborative launch of an AI Software-as-a-Service solution for hematological malignancies, guiding protocol optimization and study design for all major hematological diseases with exceptio
Show less
Read more
Impact Snapshot
Event Time:
NEO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NEO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NEO alerts
High impacting NeoGenomics, Inc. news events
Weekly update
A roundup of the hottest topics
NEO
News
- 3 Stocks Under $50 We Steer Clear Of [Yahoo! Finance]Yahoo! Finance
- NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation [Yahoo! Finance]Yahoo! Finance
- NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent LitigationBusiness Wire
- NeoGenomics to Present New ctDNA Research at SABCS 2025 [Yahoo! Finance]Yahoo! Finance
- NeoGenomics to Present New ctDNA Research at SABCS 2025Business Wire
NEO
Earnings
- 10/28/25 - Beat
NEO
Sec Filings
- 12/9/25 - Form SCHEDULE
- 12/9/25 - Form 4
- 12/3/25 - Form 4
- NEO's page on the SEC website